Skip to main content
SpringerLink
Log in
Book cover

Metabolic Effects of Gonadal Hormones and Contraceptive Steroids pp 619–634Cite as

Effect of Contraceptive Hormone Preparations on Plasma Fibrinolytic Activity

  • Chapter

Abstract

The variety of metabolic processes discussed at this conference indicates the growing interest in the effects of gonadal hormones on the organism. The introduction of progestational hormones with estrogen as oral contraceptives and the widespread use of these drugs has provided the biologist with almost unlimited material for study. Simultaneously, the unwanted side effects make the secondary effects of these hormones of importance to the clinician.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dienst, A.: Kritische Studien über die Pathogenese der Eklampsie auf Grund pathologisch-anatomischer Befunde, Blut- und Harnuntersuchungen eklamptischer Mütter und deren Früchte. Arch. Gynäk. 65: 369–464 (1902).

    Article  Google Scholar 

  2. Birnbaum, R. and Osten, A.: Untersuchungen über die Gerinnung des Blutes während der Menstruation. Arch. Gynäk. 80: 373–383 (1906).

    Article  Google Scholar 

  3. Gram, H.C.: The results of a new method for determining the fibrin percentage in blood and plasma. Acta Med. Scand. 56:107- 161 (1922).

    Article  Google Scholar 

  4. Robinson, A.J.: Clotting Factors and Fibrinolysis in Relation to Menstruation, Pregnancy, and the Use of Contraceptive Drugs. Thesis, University of North Carolina, Chapel Hill, 1965.

    Google Scholar 

  5. Sise, H.: Anovulatory hormones and blood coagulation. In Blood Coagulation, Thrombosis, and Female Hormones, Washington, D.C., (editors: T. Astrup and I.S. Wright), 1967, pp. 19–23.

    Google Scholar 

  6. Turksoy, R.N., Phillips, L.L. and Southam, A.L.: Influence of ovarian function on the fibrinolytic enzyme system. I. Ovulatory and anovulatory cycles. Amer. J. Obstet. Gynec. 82: 1211–1215 (1961).

    PubMed  CAS  Google Scholar 

  7. Egeberg, O. and Owren, P.A.: Oral contraception and blood coagulability. Brit. Med. J. 1: 220–221 (1963).

    Article  PubMed  CAS  Google Scholar 

  8. Brakman, P., Albrechtsen, O.K. and Astrup, T.: A comparative study of coagulation and fibrinolysis in blood from normal men and women. Brit. J. Haemat. 12: 74–85 (1966).

    Article  PubMed  CAS  Google Scholar 

  9. Brody, J.I. and Finch, S.C.: Improvement of factor X deficiency during pregnancy. New Engl. J. Med. 263: 996–999 (1960).

    Article  CAS  Google Scholar 

  10. Haber, S.: Norethynodrel in the treatment of factor X deficiency. Arch. Intern. Med. 114: 89–94 (1964).

    Article  PubMed  CAS  Google Scholar 

  11. Schiffman, S. and Rapaport, S.I.: Increased factor VIII levels in suspected carriers of hemophilia A taking contraceptives by mouth. New Engl. J. Med. 275: 599 (1966).

    Article  PubMed  CAS  Google Scholar 

  12. Beller, F.K. and Porges, R.F.: Blood coagulation and fibrinolytic enz3mie studies during cyclic and continuous application of progestational agents. Amer. J. Obstet. Gynec. 97: 448–459 (1967).

    PubMed  CAS  Google Scholar 

  13. Nilsson, I.M. and Kullander, S.: Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet. Gynec. Scand. 46: 286–303 (1967).

    Article  PubMed  CAS  Google Scholar 

  14. Owren, P.A.: Blood coagulation, thrombosis, and contraceptive homones. In Blood Coagulation, Thrombosis, and Female Hormones, Washington, B.C., (editors: T. Astrup and I.S. Wright), 1967, pp. 11–15.

    Google Scholar 

  15. Brakman, P., Albrechtsen, O.K. and Astrup, T.: Blood coagulation, fibrinolysis and contraceptive hormones. J. Amer. Med. Ass. 199: 69–74 (1967).

    Article  CAS  Google Scholar 

  16. Biezenski, J.J. and Moore, H.C.: Fibrinolysis in normal pregnancy. J. Clin. Path. 11: 306–310 (1958).

    Article  PubMed  CAS  Google Scholar 

  17. Brakman, P.: The fibrinolytic system in human blood during pregnancy. Amer. J. Obstet. Gynec. 94: 14–20 (1966).

    PubMed  CAS  Google Scholar 

  18. Gräfenberg, E.: Der Antitrypsingehalt des müterlichen Blutserums während der Schwangerschaft. Münch. Med. Wschr. 56: 702–704 (1909).

    Google Scholar 

  19. Maccabruni, F.: Esperienze di coltivazione “in vitro” del cancro uterino umano. Ann. Ostet. Ginec. 36: 57–65 (1914).

    Google Scholar 

  20. Guest, M.M.: Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject. J. Clin. Invest. 33: 1553–1559 (1954).

    Article  PubMed  CAS  Google Scholar 

  21. Brakman, P. and Astrup, T.: Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. Clin,. Lab. Invest. 15: 603–609 (1963).

    Article  CAS  Google Scholar 

  22. Brakman, P.: Fibrinolysis in blood during pregnancy and hormone treatment. In Blood Coagulation, Thrombosis, and Female Hormones, Washington, D.C., (editors: T. Astrup and I.S. Wright), 1967, pp. 27–32.

    Google Scholar 

  23. Shaper, A.G., Macintosh, D.M., Evans, C.M. and Kyobe, J.: Fibrinolysis and plasminogen levels in pregnancy and the puerperium. Lancet 2: 706–708 (1965).

    Article  PubMed  CAS  Google Scholar 

  24. Phillips, L.L. and Skrodelis, V.: The fibrinolytic enzyme system in normal hemorrhagic and disease states. J. Clin. Invest. 27: 965–973 (1958).

    Article  Google Scholar 

  25. Hedner, U. and Nilsson, I.M.: Determination of plasminogen in human plasma by a casein method. Thrombos. Diathes. Haemorrh. 14: 545–561 (1965).

    CAS  Google Scholar 

  26. Smith, O.W. and Smith, G.V.S.: A fibrinolytic enzyme in menstruation and late pregnancy toxemia. Science 102: 253–254 (1945).

    Article  PubMed  CAS  Google Scholar 

  27. Dausset, J., Bergerot-Blondel, Y. and Colin, M.: Fibrinolyse du sang peripherique au cours du flux menstruel physiologique. Transactions of the 6th Congress of the European Society of Haematology, Copenhagen, 1957, pp. 490–493.

    Google Scholar 

  28. Macfarlane, R.G. and Biggs, R.: Observations on fibrinolysis. Spontaneous activity associated with surgical operations, trauma, etc. Lancet 2: 862–864 (1946).

    Article  PubMed  CAS  Google Scholar 

  29. Beller, F.K., Goebelsmann, U., Douglas, G.W. and Johnson, A.: The fibrinolytic system during the menstrual cycle. Obstet. Gynec. 23: 12–16 (1964).

    PubMed  CAS  Google Scholar 

  30. Hume, R.: The relationship to age and cerebral vascular accident of fibrin and fibrinolytic activity. J. Clin. Path. 14: 167–171 (1961).

    Article  PubMed  CAS  Google Scholar 

  31. Brakman, P. and Astrup, T.: Effects of female hormones, used as oral contraceptives, on the fibrinolytic system in blood. Lancet 2: 10–12 (1964).

    Article  PubMed  CAS  Google Scholar 

  32. Brakman, P., Sobrero, A.J. and Astrup, T.: Effects of different systemic contraceptives on blood fibrinolysis. Amer. J. Obstet. Gynec. in print (1968).

    Google Scholar 

  33. Phillips, L.L., Skrodelis, V. and Furey, O.A.: The fibrinolytic enzyme system in prostatic cancer. Cancer 12: 721–730 (1959).

    Article  PubMed  CAS  Google Scholar 

  34. Phillips, L.L., Turksoy, R.N. and Southam, A.L.: Influence of ovarian function on the fibrinolytic enzyme system. II. Influence of exogenous steroids. Amer. J. Obstet. Gynec. 82: 1216–1220 (1961).

    PubMed  CAS  Google Scholar 

  35. Nagayama, M., Maki, M., Kikuchi, I., Kanbe, K., Sasaki, K. and Sasaki, Ky.: Effect of estrogens on blood clotting and plasmin systems. Tohoku J. Exp. Med. 86: 219–230 (1965).

    Article  PubMed  CAS  Google Scholar 

  36. Tagnon, H.J., Schulman, P., Whitmore, W.F. and Leone, L.A.: Prostatic fibrinolysin. Study of a case illustrating role of hemorrhagic diathesis of cancer of the prostate. Amer. J. Med. 15: 875–884 (1953).

    Article  PubMed  CAS  Google Scholar 

  37. Gillman, T., Naidoo, S.S. and Hathorn, M.: Sex differences in plasma fibrin, fibrinolytic capacity and lipids as influenced by ingested fat, gonadectomy and hormone implants; possible implications for pathogenesis of coronary occlusion. Clin. Sci. 17: 393–408 (1958).

    PubMed  CAS  Google Scholar 

  38. Fearnley, G.R.: Fibrinolysis. Edward Arnold (Publishers) Ltd., London, 1965.

    Google Scholar 

  39. Fearnley, G.R., Chakrabarti, R., Hocking, E.D. and Evans, J.F.: Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease. Lancet 2: 1008–1011 (1967).

    Article  PubMed  CAS  Google Scholar 

  40. Winther, O.: Testosterone and fibrinolytic activity. Scand. J. Clin. Lab. Invest. Suppl. 93: 207–210 (1966).

    Google Scholar 

  41. Oliver, M.D. and Boyd, G.S.: Effect of bilateral ovarieeton on coronary-artery disease and serum lipid levels. Lancet 2:690- 694 (1959).

    Article  PubMed  CAS  Google Scholar 

  42. Higano, N., Robinson, R.W. and Cohen, W.D.: Increased incidence of cardiovascular disease in castrated women. New Engl. J. Med. 268: 1123–1125 (1963).

    Article  PubMed  CAS  Google Scholar 

  43. Oliver, M.F. and Boyd, G.S.: Influence of reduction of serum lipids on prognosis of coronary heart-disease. Lancet 2: 499–505 (1961).

    Article  PubMed  CAS  Google Scholar 

  44. Stamler, J., Pick, R., Katz, L.N., Pick, A., Kaplan, B.M., Berkson, D.M. and Century, D.: Effectiveness of estrogens for therapy of myocardial infarction in middle-age men. J. Amer. Med. Ass. 183: 632–638 (1963).

    CAS  Google Scholar 

  45. Maonnorston, J., Moore, F.J., Kuzma, O.T., Magidson, O. andWeiner, J.: Effect of Premarin on survival in men with myocardial infarction. Proc. Soc. Exp. Biol. 105: 618–620 (1960).

    Google Scholar 

  46. Gore, I., Iwanaga, Y. and Gore, H.: Inhibition of dietary atherosclerosis in rabbits by Norethynodrel. J. Atheroscler. Res. 2: 361–366 (1967).

    Article  Google Scholar 

  47. Daniel, D.G., Campbell, H. and Turnbull, A.C.: Puerperal thromboembolism and suppression of lactation. Lancet 2: 287–289 (1967).

    Article  PubMed  CAS  Google Scholar 

  48. Veterans Administration Co-operative Urological Research Group: Treatment and survival of patients with cancer of the prostate. Surg. Gynec. Obstet, 124: 1011–1017 (1967).

    Google Scholar 

  49. Bailar, J.C.: Thromboembolism and oestrogen therapy. Lancet 2: 560 (1967).

    Article  PubMed  Google Scholar 

  50. Subcommittee of the Medical Research Council: Risk of thromboembolic disease in women taking oral contraceptives. Brit. Med. J. 2: 355–359 (1967).

    Article  Google Scholar 

  51. Drill, V.A. and Calhoun, D.W.: Oral contraceptives and thromboembolic disease. J. Amer. Med. Ass. 206: 77–84 (1968).

    Article  CAS  Google Scholar 

  52. Buitrago, B. and Jensen, O.M.: The effect of an oral contraceptive as a preparatory mechanism in the generalized Shwartzman reaction in rabbits. Acta Path. Microbiol. Scand. 73: 323–337 (1968).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Medical Research, The James F. Mitchell Foundation, Washington, D.C., USA

    Pieter Brakman (Senior Investigator)

Authors
  1. Pieter Brakman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard Medical School, USA

    Hilton A. Salhanick (Professor of Obstetrics and Gynecology, Member) (Professor of Obstetrics and Gynecology, Member)

  2. Center for Population Studies, Harvard School of Public Health, USA

    Hilton A. Salhanick (Professor of Obstetrics and Gynecology, Member) (Professor of Obstetrics and Gynecology, Member)

  3. Washington University School of Medicine, USA

    David M. Kipnis (Professor of Medicine) (Professor of Medicine)

  4. College of Physicians and Surgeons, Columbia University, USA

    Raymond L. Vande Wiele (Professor of Obstetrics and Gynecology) (Professor of Obstetrics and Gynecology)

Rights and permissions

Reprints and permissions

Copyright information

© 1969 Plenum Press, New York

About this chapter

Cite this chapter

Brakman, P. (1969). Effect of Contraceptive Hormone Preparations on Plasma Fibrinolytic Activity. In: Salhanick, H.A., Kipnis, D.M., Wiele, R.L.V. (eds) Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1782-1_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1782-1_46

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1784-5

  • Online ISBN: 978-1-4684-1782-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation